Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, S. M.
Right arrow Articles by Lippman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, S. M.
Right arrow Articles by Lippman, M.

Psychosomatic Medicine, Vol 50, Issue 5 520-528, Copyright © 1988 by American Psychosomatic Society

ORIGINAL ARTICLES

Survival hazards analysis in first recurrent breast cancer patients: seven-year follow-up

SM Levy, J Lee, C Bagley and M Lippman
Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, PA 15213.

The purpose of this study was to identify predictors of survival time in first recurrent breast cancer patients, including psychologic as well as biologic factors. Beginning in 1979, 36 women being treated at the National Institutes of Health for histologically proven recurrent disease were enrolled in this prospective study. At the time of data analysis, 24 had died from their malignancy. Through the use of a Cox proportional hazards model, four factors significantly entered the equation predicting survival time in the sample: Patients with a longer disease-free interval, who expressed more joy at baseline testing, who were predicted to live longer by their physicians, and who had fewer metastatic sites tended to live longer with recurrent disease than others in the sample (X2 = 22.9, p less than 0.0001). Findings from recent clinical and animal studies suggest that regulatory systems within the organism are linked and potentially influence one another. This study has demonstrated that factors at a number of levels--behavioral, as well as biologic--need to be considered in accounting for disease outcome variance.


This article has been cited by other articles:


Home page
 Psychosom. Med.Home page
Y. Chida and A. Steptoe
Positive Psychological Well-Being and Mortality: A Quantitative Review of Prospective Observational Studies
Psychosom Med, September 1, 2008; 70(7): 741 - 756.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. F. Scheier, V. S. Helgeson, R. Schulz, S. Colvin, S. Berga, M. W. Bridges, J. Knapp, K. Gerszten, and W. S. Pappert
Interventions to Enhance Physical and Psychological Functioning Among Younger Women Who Are Ending Nonhormonal Adjuvant Treatment for Early-Stage Breast Cancer
J. Clin. Oncol., July 1, 2005; 23(19): 4298 - 4311.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
L. R. Kerr, R. Hundal, W. A. Silva, J. T. Emerman, and J. Weinberg
Effects of Social Housing Condition on Chemotherapeutic Efficacy in a Shionogi Carcinoma (SC115) Mouse Tumor Model: Influences of Temporal Factors, Tumor Size, and Tumor Growth Rate
Psychosom Med, November 1, 2001; 63(6): 973 - 984.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Psychosomatic Society